Levetiracetam-Induced Seizure Aggravation in Patients With Focal Cortical Dysplasia
Journal
Clinical Neuropharmacology
Date Issued
2018
Author(s)
Babunovska, Marija
Boshkovski, Bojan
Aleksovska, Katina
DOI
10.1097/WNF.0000000000000304
Abstract
The choice of antiepileptic drug is typically based on seizure type, and there is no evidence for superior effectiveness or potential deterioration of particular antiepileptic drug in specific etiologic subgroups. The aim of the study was to identify etiological factor(s) associated with increased risk of seizure aggravation with levetiracetam (LEV).
